Synthesis of insulin derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6323311
SERIAL NO

09400942

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method for the 'one-pot' synthesis of insulin derivatives wherein insulin is modified at the .alpha.-amino group of the PheB1 residue is described. The method comprises protecting the .alpha.-amino group of the GlyA1 residue and the .epsilon.-amino group of the LysB29 residue by reaction of insulin with a cyclic anhydride of a dicarboxylic acid in the presence of a tertiary amine. The protected insulin is then reacted with an activated hydrophilic compound, preferably an activated polyethylene glycol, resulting in a conjugate of the hydrophilic compound coupled to the PheB1 residue of insulin. The protecting groups are then removed from the conjugate under mild acidic conditions, and the resulting insulin derivative can be purified by conventional methods. Monosubstituted insulin derivatives wherein polyethylene glycol or derivatives thereof or glycosides are coupled to the PheB1 residue of insulin are also described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UTAH RESEARCH FOUNDATION UNIVERSITY OF615 ARAPEEN DRIVE SUITE 110 SALT LAKE CITY UT 84108

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Baudys, Miroslav Salt Lake City, UT 8 132
Kim, Sung Wan Salt Lake City, UT 57 592
Liu, Feng Salt Lake City, UT 583 7601

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation